Patterns of physical co-/multi-morbidity among patients with serious mental illness: a London borough-based cross-sectional study

Charlotte Woodhead, Mark Ashworth, Peter Schofield, Max Henderson, Charlotte Woodhead, Mark Ashworth, Peter Schofield, Max Henderson

Abstract

Background: Serious mental illness (SMI) is associated with elevated mortality compared to the general population; the majority of this excess is attributable to co-occurring common physical health conditions. There may be variation within the SMI group in the distribution of physical co/multi-morbidity. This study aims to a) compare the pattern of physical co- and multi-morbidity between patients with and without SMI within a South London primary care population; and, b) to explore socio-demographic and health risk factors associated with excess physical morbidity among the SMI group.

Methods: Data were obtained from Lambeth DataNet, a database of electronic patient records derived from general practices in the London borough of Lambeth. The pattern of 12 co-morbid common physical conditions was compared by SMI status. Multivariate ordinal and logistic regression analyses were conducted to assess the strength of association between each condition and SMI status; adjustments were made for potentially confounding socio-demographic characteristics and for potentially mediating health risk factors.

Results: While SMI patients were more frequently recorded with all 12 physical conditions than non-SMI patients, the pattern of co-/multi-morbidity was similar between the two groups. Adjustment for socio-demographic characteristics - in particular age and, to a lesser extent ethnicity, considerably reduced effect sizes and accounted for some of the associations, though several conditions remained strongly associated with SMI status. Evidence for mediation by health risk factors, in particular BMI, was supported.

Conclusions: SMI patients are at an elevated risk of a range of physical health conditions than non-SMI patients but they do not appear to experience a different pattern of co-/multimorbidity among those conditions considered. Socio-demographic differences between the two groups account for some of the excess in morbidity and known health risk factors are likely to mediate the association. Further work to examine a wider range of conditions and health risk factors would help determine the extent of excess mortality attributable to these factors.

Figures

Figure 1
Figure 1
Percentage (%) of SMI and non-SMI patients recorded with each physical health condition.

References

    1. Department of Health. No health without mental health. London: TSO; 2011.
    1. Crump C, Sundquist K, Sundquist J. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatr. 2013;170:324–333. doi: 10.1176/appi.ajp.2012.12050599.
    1. Henderson M, Hotopf M, Imran S, Hayes RD, Kuh D. Psychiatric disorder in early adulthood and risk of premature mortality in the 1946 British Birth Cohort. BMC Psychiatr. 2011;11(1):37. doi: 10.1186/1471-244X-11-37. doi:10.1186/1471-244X-11-37.
    1. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ. 2013;346:f2539. doi: 10.1136/bmj.f2539.
    1. Chang C-K, Hayes RD, Perera G, Broadbent MTM, Fernandes AC, Lee WE, Hotopf M, Stewart R. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS ONE. 2011;6(5):e19590. doi: 10.1371/journal.pone.0019590.
    1. Laursen TM, Munk Olsen T, Vestergaard M. Life expectancy and cardiovascular mortality in persons with schizophrenia. Curr Opin Psychiatr. 2012;25(2):83–88. doi: 10.1097/YCO.0b013e32835035ca.
    1. Brown S, Kim M, Mitchell C, Inskip H. Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatr. 2010;196(2):116–121. doi: 10.1192/bjp.bp.109.067512.
    1. Dutta R, Murray RM, Allardyce J, Jones PB, Boydell JE. Mortality in first-contact psychosis patients in the UK: a cohort study. Psychol Med. 2012;42(8):1649–1661. doi: 10.1017/S0033291711002807.
    1. Kemp DE, DeHert M, Rahman Z, Fyans P, Eudicine JM, Marler SV, Baker RA, Carlson BX. Investigation into the long-term metabolic effects of aripiprazole adjunctive to lithium, valproate, or lamotrigine. J Affect Disord. 2013;148(1):84–91. doi: 10.1016/j.jad.2012.11.054.
    1. Scheen AJ, De Hert MA. Abnormal glucose metabolism in patients treated with antipsychotics. Diabetes Metabol. 2007;33(3):169–175. doi: 10.1016/j.diabet.2007.01.003.
    1. McElroy SL. Obesity in patients with severe mental illness: overview and management. J Clin Psychiatr. 2009;70(suppl. 3):12–21.
    1. Myles N, Newall HD, Curtis J, Nielssen O, Shiers D, Large M. Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis. J Clin Psychiatr. 2012;73(4):468–475. doi: 10.4088/JCP.11r07222.
    1. Mitchell AJ, Lawrence D. Revascularisation and mortality rates following acute coronary syndromes in people with severe mental illness: comparative meta-analysis. Br J Psychiatr. 2011;198(6):434–441. doi: 10.1192/bjp.bp.109.076950.
    1. Mitchell AJ, Lord O. Review: do deficits in cardiac care influence high mortality rates in schizophrenia? A systematic review and pooled analysis. J Psychopharmacol. 2010;24(suppl. 4):69–80.
    1. Mitchell AJ, Lord O, Malone D. Differences in the prescribing of medication for physical disorders in individuals with v. without mental illness: meta-analysis. Br J Psychiatr. 2012;201(6):435–443. doi: 10.1192/bjp.bp.111.094532.
    1. Wildes JE, Marcus MD, Fagiolini A. Obesity in patients with bipolar disorder: a biopsychosocial-behavioral model. Clin J Psychiatr. 2006;67(6):904–915. doi: 10.4088/JCP.v67n0607.
    1. Smith DJ, Langan J, McLean G, Guthrie B, Mercer SW. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open. 2013;3(4):e002808.
    1. Department for Communities and Local Government. English indices of Deprivation 2010. London: TSO; 2011.
    1. Hatch S, Frissa S, Verdecchia M, Stewart R, Fear NT, Reichenberg A, Morgan C, Kankulu B, Clark J, Gazard B, Medcalf R, Hotopf M. the SELCoH study team. Identifying socio-demographic and socioeconomic determinants of health inequalities in a diverse London community: the South East London Community Health (SELCoH) study. BMC Publ Health. 2011;11(1):861. doi: 10.1186/1471-2458-11-861.
    1. Osborn DJ, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s general practice research database. Arch Gen Psychiatr. 2007;64(2):242–249. doi: 10.1001/archpsyc.64.2.242.
    1. Pinto R, Ashworth M, Seed P, Rowlands G, Schofield P, Jones R. Differences in the primary care management of patients with psychosis from two ethnic groups: a population-based cross-sectional study. Fam Pract. 2010;27(4):439–446. doi: 10.1093/fampra/cmq014.
    1. Suvisaari J, Partti K, Perala J, Viertiö S, Saarni SE, Lönngvist J, Saarni SI, Härkänen T. Mortality and its determinants in people with psychotic disorder. Psychosom Med. 2013;75(1):60–67.
    1. DeHert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, Detraux J, Gautam S, Möller HJ, Ndetei DM, Newcomer JW, Uwakwe R, Leucht S. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatr. 2011;10(1):52–77.
    1. Chacon F, Mora F, Gervas-Rios A, Gilaberte I. Efficacy of lifestyle interventions in physical health management of patients with severe mental illness. Ann Gen Psychiatr. 2011;10(1):22. doi: 10.1186/1744-859X-10-22.
    1. Khazaal Y, Fresard E, Rabia S, Chatton A, Rothen S, Pomini V, Grasset F, Borgeat F, Zullino D. Cognitive behavioural therapy for weight gain associated with antipsychotic drugs. Schizophr Res. 2007;91(1–3):169–177.
    1. Iestra JA, Kromhout D, van der Schouw YT, Grobbee DE, Boshuizen HC, van Staveren WA. Effect size estimates of lifestyle and dietary changes on all-cause mortality in coronary artery disease patients: a systematic review. Circulation. 2005;112(6):924–934. doi: 10.1161/CIRCULATIONAHA.104.503995.
    1. Andreassen OA, Djurovic S, Thompson WK, Schork AJ, Kendler KS, O’Donovan MC, Rujescu D, Werge T, van de Bunt M, Morris AP, McCarthy MI, Roddey JC, McEvoy LK, Desikan RS, Dale AM. International Consortium for Blood Pressure GWAS; Diabetes Genetics Replication and Meta-analysis Consortium; Psychiatric Genomics Consortium Schizophrenia Working Group. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am J Hum Genet. 2013;92(2):197–209. doi: 10.1016/j.ajhg.2013.01.001.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する